C. Gessner, B. Akyıldız, D. Nachtigall, E. Nudo, S. Boeing, H. Timmermann
{"title":"使用炎症参数在哮喘患者的护理处方外单吸入器三联治疗:来自德国的现实世界的观点","authors":"C. Gessner, B. Akyıldız, D. Nachtigall, E. Nudo, S. Boeing, H. Timmermann","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1239","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany\",\"authors\":\"C. Gessner, B. Akyıldız, D. Nachtigall, E. Nudo, S. Boeing, H. Timmermann\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1239\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":262576,\"journal\":{\"name\":\"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1239\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1239","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany